TransDigm Group Files 8-K Report
Ticker: TDG · Form: 8-K · Filed: May 28, 2024 · CIK: 1260221
| Field | Detail |
|---|---|
| Company | Transdigm Group Inc (TDG) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $655 million, $90 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: TDG
TL;DR
TDG filed an 8-K, likely routine docs, no major news yet.
AI Summary
On May 28, 2024, TransDigm Group Incorporated filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial transactions or material events were detailed in the provided excerpt, suggesting it may be a routine filing or related to exhibit submissions.
Why It Matters
This filing indicates TransDigm Group is providing updates or submitting required documentation to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing excerpt provided is a standard SEC form submission without disclosure of any new material risks or events.
Key Numbers
- 001-32833 — SEC File Number (Identifies the company's filing with the SEC.)
- 41-2101738 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- TransDigm Group Incorporated (company) — Registrant
- May 28, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 1350 Euclid Avenue, Suite 1600, Cleveland, Ohio 44115 (address) — Principal executive offices
FAQ
What specific "Other Events" are being reported by TransDigm Group?
The provided excerpt does not detail the specific "Other Events" being reported, only that this item is included in the 8-K filing.
What "Financial Statements and Exhibits" are being filed with this 8-K?
The excerpt states that "Financial Statements and Exhibits" are part of the filing, but does not list the specific documents included.
Is this filing related to any recent acquisitions or divestitures by TransDigm Group?
The provided text does not mention any acquisitions or divestitures; it lists "Other Events" and "Financial Statements and Exhibits" as the primary items.
What is the significance of the filing date May 28, 2024?
May 28, 2024, is the date of the report and the earliest event reported, indicating when the company is officially submitting this information to the SEC.
Does the filing indicate any changes in TransDigm Group's principal executive offices?
No, the filing lists the principal executive offices at 1350 Euclid Avenue, Suite 1600, Cleveland, Ohio 44115, and does not indicate any changes.
Filing Stats: 576 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2024-05-28 07:34:04
Key Financial Figures
- $0.01 — nge on which registered: Common Stock, $0.01 par value TDG New York Stock Exchange
- $655 million — red Capital Partners, for approximately $655 million in cash, including certain tax benefits
- $90 million — y is expected to generate approximately $90 million in revenue for the calendar year ending
Filing Documents
- tdg-20240528.htm (8-K) — 36KB
- exhibit991pressreleaserapt.htm (EX-99.1) — 11KB
- image_1a.jpg (GRAPHIC) — 159KB
- 0001260221-24-000054.txt ( ) — 393KB
- tdg-20240528.xsd (EX-101.SCH) — 2KB
- tdg-20240528_lab.xml (EX-101.LAB) — 22KB
- tdg-20240528_pre.xml (EX-101.PRE) — 13KB
- tdg-20240528_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On May 28, 2024, TransDigm Group Incorporated ("TransDigm Group") issued a press release (the "Press Release") announcing its definitive agreement to acquire Raptor Labs Holdco, LLC ("Raptor Scientific" or the "Company"), a portfolio company of L Squared Capital Partners, for approximately $655 million in cash, including certain tax benefits. A copy of this Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. Raptor Scientific is a leading global manufacturer of complex test and measurement solutions primarily serving the aerospace and defense end markets. The Company's products are highly engineered, proprietary components with significant aftermarket content and a strong presence across major aerospace and defense platforms. Nearly all of Raptor Scientific's revenue is generated from proprietary products. The Company employs approximately 170 people and has manufacturing locations in Livermore, CA; Woodland Hills, CA; Berlin, CT; Huntsville, AL; and Peterborough, NH. The Company is expected to generate approximately $90 million in revenue for the calendar year ending December 31, 2024. The acquisition is subject to regulatory approvals in the United States and customary closing conditions. The acquisition is expected to be financed through existing cash on hand.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSDIGM GROUP INCORPORATED By: /s/ Sarah Wynne Name: Sarah Wynne Title: Chief Financial Officer (Principal Financial Officer) Dated: May 28, 2024